Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: Findings from the Fabry Registry

@article{Watt2010AgalsidaseBT,
  title={Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: Findings from the Fabry Registry},
  author={Torquil Watt and A Burlina and Chiara Cazzorla and Dorothee Sch{\"o}nfeld and Maryam Banikazemi and Robert J Hopkin and Ana M Martins and Katherine Sims and Dana Beitner-Johnson and Fanny O'brien and Ulla Feldt-Rasmussen},
  journal={Genetics in Medicine},
  year={2010},
  volume={12},
  pages={703-712}
}
Disclosure: The Fabry Registry is sponsored by Genzyme Corporation. U.F.-R., K.S., R.J.H., M.B., A.M., and A.P.B. serve on the Genzyme-sponsored Fabry Registry Boards of Advisors. D.B.-J. and F.O.B. are full-time employees of Genzyme Corporation. T.W. has received unrestricted grants from Genzyme for other research projects.Purpose: To evaluate the effect of agalsidase beta on longitudinal health-related quality of life in patients with Fabry disease.Methods: The SF-36® Health Survey was used… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

Fabry's disease.

Journal of the neurological sciences • 2014
View 6 Excerpts
Highly Influenced

JIMD Reports, Volume 38

JIMD Reports • 2018
View 4 Excerpts
Highly Influenced

Psychological health in adults with morquio syndrome.

JIMD reports • 2015
View 8 Excerpts
Highly Influenced

Enzyme replacement therapy for Fabry disease: some answers but more questions

Therapeutics and clinical risk management • 2011
View 13 Excerpts
Highly Influenced

Neurometabolic Hereditary Diseases of Adults

Springer International Publishing • 2018
View 2 Excerpts

Neuropathic Pain in Fabry Disease

Hande Türker, Cetin Kursad Akpınar, Ayşe Oytun Bayrak
2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 37 references

: a randomized , double - blind , placebo - controlled trial of a flexible - dose regimen

N Weinreb, J Barranger, S Packman
2008

Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2008
View 1 Excerpt

Similar Papers

Loading similar papers…